HOSPIRA, INC. for HOSPIRA INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trade
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Copyright/Patent/Trademark CPT
IP
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Budget/Appropriations BUD
H.J.Res.117 Continuing Appropriations Resolution, 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
Health Issues HCR
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL DOWELL | — |
| JULIANA REED | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.